Mindbio Therapeutics Corp. (MBIO) Price & Analysis

14 Followers

MBIO Stock Chart & Stats

C$1.04

>-C$0.01(-20.00%)

At close: Jan 07 4:00 PM EST

C$1.04

>-C$0.01(-20.00%)

Day’s Range― - ―

52-Week RangeC$0.25 - C$6.00

Previous CloseN/A

Volume53.00K

Average Volume (3M)131.85K

Market Cap

C$1.89M

Enterprise ValueC$6.18M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta3.17

Next Earnings

Nov 04, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.27

Shares Outstanding7,283,063

10 Day Avg. Volume111,998

30 Day Avg. Volume131,850

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Mindbio Therapeutics Corp. News

MindBio Hires Venture Liquidity Providers to Support Market Making on CSE

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) has provided an announcement. MindBio Therapeutics has engaged Venture Liquidity Providers to...

3M ago

MindBio launches Intox Collect to scale AI-driven intoxication detection

An update from Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) is now available. MindBio Therapeutics Corp., a biotechnology company...

3M ago

MindBio Raises $1.44 Million and Launches Marketing Push for Intoxication Detection Tech

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) has issued an update. MindBio Therapeutics has closed an upsized non-brokered private...

3M ago

MindBio Boosts Private Placement to $1.5 Million for AI Intoxication Platform

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) just unveiled an announcement. MindBio Therapeutics has increased the size of its...

4M ago

MindBio to Raise Up to $650,000 for AI Intoxication Detection Expansion in Mining Sector

The latest announcement is out from Mindbio Therapeutics Corp. ( ($TSE:MBIO) ). MindBio Therapeutics plans to raise up...

4M ago

MindBio taps Chilean policy veteran to drive AI impairment screening push in South American mining

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) has provided an announcement. MindBio Therapeutics has appointed Chilean drug and alcohol...

4M ago

MindBio Builds Edge AI Hardware Platform for Voice-Based Intoxication Detection in Mining

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) has provided an update. MindBio Therapeutics is moving beyond software-only offerings by...

4M ago

MindBio Expands Voice AI Intoxication Screening into South American Mining Sector

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) has issued an update. MindBio Therapeutics has deployed a team of software...

5M ago

MindBio Targets Mining Sector With AI Voice-Based Drug and Alcohol Screening Platform

An announcement from Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) is now available. MindBio Therapeutics Corp. is advancing commercialization...

5M ago

MindBio Moves Into Global Digital Health Market With AI Voice-Based Intoxication Diagnostics

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) has provided an announcement. MindBio Therapeutics has begun targeting the global digital...

5M ago

MBIO FAQ

What was Mindbio Therapeutics Corp.’s price range in the past 12 months?

Mindbio Therapeutics Corp. lowest stock price was C$0.24 and its highest was C$6.00 in the past 12 months.

What is Mindbio Therapeutics Corp.’s market cap?

Mindbio Therapeutics Corp.’s market cap is C$1.89M.

When is Mindbio Therapeutics Corp.’s upcoming earnings report date?

Mindbio Therapeutics Corp.’s upcoming earnings report date is Nov 04, 2026 which is in 124 days.

How were Mindbio Therapeutics Corp.’s earnings last quarter?

Mindbio Therapeutics Corp. released its earnings results on Jun 01, 2026. The company reported -C$0.269 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.269.

Is Mindbio Therapeutics Corp. overvalued?

According to Wall Street analysts Mindbio Therapeutics Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Mindbio Therapeutics Corp. pay dividends?

Mindbio Therapeutics Corp. does not currently pay dividends.

What is Mindbio Therapeutics Corp.’s EPS estimate?

Mindbio Therapeutics Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Mindbio Therapeutics Corp. have?

Mindbio Therapeutics Corp. has 7,283,063 shares outstanding.

What happened to Mindbio Therapeutics Corp.’s price movement after its last earnings report?

Mindbio Therapeutics Corp. reported an EPS of -C$0.269 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8.333%.

Which hedge fund is a major shareholder of Mindbio Therapeutics Corp.?

Currently, no hedge funds are holding shares in TSE:MBIO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Mindbio Therapeutics Corp.

MindBio Therapeutics Corp. operates as a clinical stage drug development company. It is involved in the clinical research into the microdosing of psychedelic medicines to treat a range of medical conditions, such as depression, anxiety, PTSD, panic disorder, chronic pain, and opiate addictions. The company is based in Melbourne, Australia.